Cargando…
Combining dendritic cells and B cells for presentation of oxidised tumour antigens to CD8(+) T cells
The dendritic cell (DC) is the foremost antigen-presenting cell (APC) for ex vivo expansion of tumour-specific patient T cells. Despite marked responses in some patients following reinfusion of DC-activated autologous or HLA-matched donor T cells, overall response rates remain modest in solid tumour...
Autores principales: | Grant, Melanie L, Shields, Nicholas, Neumann, Silke, Kramer, Katrin, Bonato, Andrea, Jackson, Christopher, Baird, Margaret A, Young, Sarah L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539416/ https://www.ncbi.nlm.nih.gov/pubmed/28791124 http://dx.doi.org/10.1038/cti.2017.28 |
Ejemplares similares
-
Data on the uptake of reducible antigen-adjuvant conjugates by dendritic cells
por: Kramer, Katrin, et al.
Publicado: (2019) -
Cancer-associated fibroblasts induce antigen-specific deletion of CD8(+) T Cells to protect tumour cells
por: Lakins, Matthew A., et al.
Publicado: (2018) -
Adoptive cell therapy with CD4(+) T helper 1 cells and CD8(+) cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of endogenous memory responses to non-targeted tumour epitopes
por: Li, Kunyu, et al.
Publicado: (2017) -
CD8+ T Cell Priming by Dendritic Cell Vaccines Requires Antigen Transfer to Endogenous Antigen Presenting Cells
por: Yewdall, Alice W., et al.
Publicado: (2010) -
Monocytic Cell Adhesion to Oxidised Ligands: Relevance to Cardiovascular Disease
por: Poston, Robin N., et al.
Publicado: (2022)